Redox-responsive polymer-drug conjugates based on doxorubicin and chitosan oligosaccharide-g-stearic acid for cancer therapy.
暂无分享,去创建一个
Hong Yuan | Jian You | Fuqiang Hu | Yingwen Hu | Xuan Huang | Hong Yuan | F. Hu | Yongzhong Du | Jian You | Yigang Su | Xuan Huang | Jiabei He | Ying-wen Hu | Jia-bei He | Yihan Su | Yongzhong Du | Yongzhong Du | Yongzhong Du
[1] James B. Mitchell,et al. Noninvasive imaging of tumor redox status and its modification by tissue glutathione levels. , 2002, Cancer research.
[2] Chun Xing Li,et al. Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres. , 2013, Biomaterials.
[3] H. Hamana,et al. Synthesis of carboxymethylpullulan-peptide-doxorubicin conjugates and their properties. , 1995, Chemical & pharmaceutical bulletin.
[4] A J Sinskey,et al. Oxidized redox state of glutathione in the endoplasmic reticulum. , 1992, Science.
[5] G. Hart,et al. Nuclear pore complex glycoproteins contain cytoplasmically disposed O- linked N-acetylglucosamine , 1987, The Journal of cell biology.
[6] T. Okano,et al. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[7] Yan Xia,et al. Drug-loaded, bivalent-bottle-brush polymers by graft-through ROMP. , 2010, Macromolecules.
[8] K. Ulbrich,et al. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. , 2010, Biomaterials.
[9] Kazuo Tanaka,et al. Heavy metal-free 19F NMR probes for quantitative measurements of glutathione reductase activity using silica nanoparticles as a signal quencher. , 2012, Bioorganic & Medicinal Chemistry.
[10] S. Santra,et al. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy. , 2011, Journal of the American Chemical Society.
[11] S. Zeng,et al. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. , 2006, International journal of pharmaceutics.
[12] S. Kannan,et al. Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery. , 2009, Biomaterials.
[13] Duxin Sun,et al. Superparamagnetic iron oxide nanotheranostics for targeted cancer cell imaging and pH-dependent intracellular drug release. , 2010, Molecular pharmaceutics.
[14] Hong Yuan,et al. Synthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micelles. , 2009, Biomaterials.
[15] Chulhun Kang,et al. Disulfide-cleavage-triggered chemosensors and their biological applications. , 2013, Chemical reviews.
[16] G. Takemura,et al. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. , 2007, Progress in cardiovascular diseases.
[17] R. Freidinger,et al. The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy. , 2001, Journal of medicinal chemistry.
[18] Xing Guo,et al. pH-triggered intracellular release from actively targeting polymer micelles. , 2013, Biomaterials.
[19] S. Kannan,et al. Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] P. Couvreur,et al. Prodrug-based intracellular delivery of anticancer agents. , 2011, Advanced drug delivery reviews.
[21] K. Ulbrich,et al. Biodegradable star HPMA polymer-drug conjugates: Biodegradability, distribution and anti-tumor efficacy. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[22] C. Tung,et al. Proteolysis: a biological process adapted in drug delivery, therapy, and imaging. , 2009, Bioconjugate chemistry.
[23] Felix Kratz,et al. Polymer therapeutics: concepts and applications. , 2006, Angewandte Chemie.
[24] Yiyu Cheng,et al. Quantitative study of the drug efflux kinetics from sensitive and MDR human breast cancer cells. , 2007, Biochimica et biophysica acta.
[25] J. Ljubimova,et al. Nanomedicine therapeutic approaches to overcome cancer drug resistance. , 2013, Advanced drug delivery reviews.
[26] Hong Yuan,et al. Coadministration of glycolipid-like micelles loading cytotoxic drug with different action site for efficient cancer chemotherapy , 2009, Nanotechnology.
[27] Hong Yuan,et al. Effect of proteins with different isoelectric points on the gene transfection efficiency mediated by stearic acid grafted chitosan oligosaccharide micelles. , 2013, Molecular pharmaceutics.
[28] Jianping Zhou,et al. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel. , 2012, Biomaterials.
[29] S. Zeng,et al. Shell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxel. , 2006, Colloids and surfaces. B, Biointerfaces.
[30] Jayant Khandare,et al. Polymer-drug conjugates: Progress in polymeric prodrugs , 2006 .
[31] R. Weissleder,et al. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.
[32] I. Kwon,et al. Preparation of chitosan self-aggregates as a gene delivery system. , 1998, Journal of controlled release : official journal of the Controlled Release Society.